Jamerson, Kenneth A <br/><br/>
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.  [electronic resource] 

 -  American journal of hypertension  Jun 2004 
 - 495-501 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0895-7061 
<br/><br/><label>Standard No.: </label>10.1016/j.amjhyper.2004.02.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amlodipine--administration & dosage<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Antihypertensive Agents--administration & dosage<br/>Benzazepines--administration & dosage<br/>Blood Pressure--drug effects<br/>Calcium Channel Blockers--administration & dosage<br/>Diastole--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Edema--chemically induced<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Severity of Illness Index<br/>Systole--drug effects<br/>Treatment Outcome